Literature DB >> 14722267

Nuclear localization but not PML protein is required for incorporation of the papillomavirus minor capsid protein L2 into virus-like particles.

Katrin A Becker1, Luise Florin, Cornelia Sapp, Gerd G Maul, Martin Sapp.   

Abstract

Recent reports suggest that nuclear domain(s) 10 (ND10) is the site of papillomavirus morphogenesis. The viral genome replicates in or close to ND10. In addition, the minor capsid protein, L2, accumulates in these subnuclear structures and recruits the major capsid protein, L1. We have now used cell lines deficient for promyelocytic leukemia (PML) protein, the main structural component of ND10, to study the role of this nuclear protein for L2 incorporation into virus-like particles (VLPs). L2 expressed in PML protein knockout (PML(-/-)) cells accumulated in nuclear dots, which resemble L2 aggregates forming at ND10 in PML protein-containing cells. These L2 assemblies also attracted L1 and the transcriptional repressor Daxx, suggesting that they are functional in the absence of PML protein. In addition, L2-containing VLPs assembled in PML(-/-) cells. In order to analyze whether incorporation of L2 into VLPs requires any specific subcellular localization, an L1 mutant defective for nuclear transport and L2 mutants deficient in nuclear translocation and/or ND10 localization were constructed. Using this approach, we identified two independent L2 domains interacting with L1. Mutant L2 proteins not accumulating in ND10 were incorporated into VLPs. Mutant L1 protein, which assembled into VLPs in the cytoplasm, did not incorporate L2 defective for nuclear translocation. The same mutant L2 protein, which passively diffuses into the nucleus, is incorporated into wild-type L1-VLPs in the nucleus. Our data demonstrate that the incorporation of L2 into VLPs requires nuclear but not ND10 localization.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14722267      PMCID: PMC321415          DOI: 10.1128/jvi.78.3.1121-1128.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

1.  Carboxyl terminus of bovine papillomavirus type-1 L1 protein is not required for capsid formation.

Authors:  J Paintsil; M Müller; M Picken; L Gissmann; J Zhou
Journal:  Virology       Date:  1996-09-01       Impact factor: 3.616

2.  Generation and neutralization of pseudovirions of human papillomavirus type 33.

Authors:  F Unckell; R E Streeck; M Sapp
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

3.  Novel structural features of bovine papillomavirus capsid revealed by a three-dimensional reconstruction to 9 A resolution.

Authors:  B L Trus; R B Roden; H L Greenstone; M Vrhel; J T Schiller; F P Booy
Journal:  Nat Struct Biol       Date:  1997-05

4.  Papillomavirus capsid binding and uptake by cells from different tissues and species.

Authors:  M Müller; L Gissmann; R J Cristiano; X Y Sun; I H Frazer; A B Jenson; A Alonso; H Zentgraf; J Zhou
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

5.  The major immediate-early proteins IE1 and IE2 of human cytomegalovirus colocalize with and disrupt PML-associated nuclear bodies at very early times in infected permissive cells.

Authors:  J H Ahn; G S Hayward
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

Review 6.  Nuclear dots: actors on many stages.

Authors:  T Sternsdorf; T Grötzinger; K Jensen; H Will
Journal:  Immunobiology       Date:  1997-12       Impact factor: 3.144

7.  In vitro generation and type-specific neutralization of a human papillomavirus type 16 virion pseudotype.

Authors:  R B Roden; H L Greenstone; R Kirnbauer; F P Booy; J Jessie; D R Lowy; J T Schiller
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

8.  The papillomavirus minor capsid protein, L2, induces localization of the major capsid protein, L1, and the viral transcription/replication protein, E2, to PML oncogenic domains.

Authors:  P M Day; R B Roden; D R Lowy; J T Schiller
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

9.  Conformational and linear epitopes on virus-like particles of human papillomavirus type 33 identified by monoclonal antibodies to the minor capsid protein L2.

Authors:  C Volpers; M Sapp; P J Snijders; J M Walboomers; R E Streeck
Journal:  J Gen Virol       Date:  1995-11       Impact factor: 3.891

10.  Human cytomegalovirus immediate early interaction with host nuclear structures: definition of an immediate transcript environment.

Authors:  A M Ishov; R M Stenberg; G G Maul
Journal:  J Cell Biol       Date:  1997-07-14       Impact factor: 10.539

View more
  22 in total

1.  Nuclear translocation of papillomavirus minor capsid protein L2 requires Hsc70.

Authors:  Luise Florin; Katrin A Becker; Cornelia Sapp; Carsten Lambert; Hüseyin Sirma; Martin Müller; Rolf E Streeck; Martin Sapp
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

2.  A membrane-destabilizing peptide in capsid protein L2 is required for egress of papillomavirus genomes from endosomes.

Authors:  Nadine Kämper; Patricia M Day; Thorsten Nowak; Hans-Christoph Selinka; Luise Florin; Jan Bolscher; Lydia Hilbig; John T Schiller; Martin Sapp
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

Review 3.  DNA virus replication compartments.

Authors:  Melanie Schmid; Thomas Speiseder; Thomas Dobner; Ramon A Gonzalez
Journal:  J Virol       Date:  2013-11-20       Impact factor: 5.103

4.  Evidence for a role of the cellular ND10 protein PML in mediating intrinsic immunity against human cytomegalovirus infections.

Authors:  Nina Tavalai; Peer Papior; Sabine Rechter; Martina Leis; Thomas Stamminger
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

5.  Chaperone-mediated in vitro disassembly of polyoma- and papillomaviruses.

Authors:  Laura R Chromy; Amy Oltman; Patricia A Estes; Robert L Garcea
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

6.  Identification of a dynein interacting domain in the papillomavirus minor capsid protein l2.

Authors:  Luise Florin; Katrin A Becker; Carsten Lambert; Thorsten Nowak; Cornelia Sapp; Dennis Strand; Rolf E Streeck; Martin Sapp
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

7.  Human papillomavirus 16 minor capsid protein L2 helps capsomeres assemble independently of intercapsomeric disulfide bonding.

Authors:  Yoshiyuki Ishii; Saori Ozaki; Keiko Tanaka; Tadahito Kanda
Journal:  Virus Genes       Date:  2005-12       Impact factor: 2.332

8.  Interferon Kappa Inhibits Human Papillomavirus 31 Transcription by Inducing Sp100 Proteins.

Authors:  Christina Habiger; Günter Jäger; Michael Walter; Thomas Iftner; Frank Stubenrauch
Journal:  J Virol       Date:  2015-10-21       Impact factor: 5.103

9.  Expression pattern and subcellular localization of human papillomavirus minor capsid protein L2.

Authors:  Zhenhua Lin; Anna V Yemelyanova; Ratish Gambhira; Subhashini Jagu; Craig Meyers; Reinhard Kirnbauer; Brigitte M Ronnett; Patti E Gravitt; Richard B S Roden
Journal:  Am J Pathol       Date:  2008-12-18       Impact factor: 4.307

Review 10.  L2, the minor capsid protein of papillomavirus.

Authors:  Joshua W Wang; Richard B S Roden
Journal:  Virology       Date:  2013-05-17       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.